• PRMT5 Splicing Vulnerability in MYCN Neuroblastoma

  2026-09-02

  The reference study shows that MYCN-amplified neuroblastoma depends on PRMT5-regulated RNA splicing, with downstream disruption of epitranscriptomic control and glutamine metabolism. Its integrated transcriptomic, isotope-tracing, molecular, and in vivo experiments identify GLS regulation as a mechanistic link between spliceosomal stress and tumor-cell survival.

• Laminin (925-933) for Reliable Cell Assays

  2026-09-01

  A scenario-based guide to using Laminin (925-933), SKU A1023, to control cell attachment, migration, and chemotaxis variables that can complicate viability and cytotoxicity assays. It covers formulation, concentration selection, controls, interpretation, and practical vendor evaluation.

• PX-478 2HCl in Hypoxia Research

  2026-08-31

  PX-478 2HCl is a practical HIF-1α inhibition tool for paired normoxic–hypoxic cell assays, radiosensitization studies, tumor ischemia models, and prenatal hypoxia research. Its value is strongest when molecular target engagement is combined with functional, histological, or reporter-based readouts.

• Beyond G1 Arrest: Translational Strategy for LEE011

  2026-08-31

  Ribociclib succinate is more than a tool for producing G1 arrest: it enables translational researchers to connect CDK4/6 biology with formulation control, orthogonal assay design, combination strategy, and biomarker-led decision-making. This article distinguishes established evidence from testable hypotheses and explains how LEE011 succinate can strengthen cancer research workflows beyond the scope of a conventional product page.

• ICAA, RIP3, and Ang II Cardiac Hypertrophy

  2026-08-30

  The reference study identifies isochlorogenic acid A as a direct regulator of RIP3 that suppresses the RIP3/CaMKII axis during angiotensin II- and pressure overload-induced cardiac hypertrophy. Its most important advance is showing that RIP3 contributes to hypertrophic remodeling independently of MLKL, suggesting a mechanism distinct from canonical necroptosis.

• BMS 599626 dihydrochloride EGFR Workflow

  2026-08-29

  Build a reproducible EGFR/HER2 assay workflow around BMS 599626 dihydrochloride, from receptor phosphorylation to long-term proliferation. The guide also shows how machine-learning senolytic research can sharpen model selection without overstating evidence for a senolytic effect.

• DOTAP for Cationic Nucleic Acid Delivery

  2026-08-29

  1,2-Dioleoyl-3-trimethylammonium-propane chloride, commonly called DOTAP, is a synthetic cationic lipid for formulation-dependent delivery of DNA, RNA, and antisense oligonucleotides. Its value is highest when charge-mediated complexation, cell-specific optimization, and endosomal-release controls are treated as separate experimental variables.

• Salmonella Haem, SirM, and Macrophage Phagocytosis

  2026-08-28

  A recent Nature Microbiology study identifies SirM-mediated modification of HemL as a mechanism that increases Salmonella haem production, suppresses macrophage phagocytosis, and promotes virulence in mice. The work expands the role of bacterial haem beyond iron acquisition and provides a mechanistic framework for studying pathogen metabolism, innate immune evasion, and host–microbe competition.

• L-Threonine for Metabolic and ALP Assays

  2026-08-28

  L-Threonine enables controlled nutrient perturbation in cell culture optimization, metabolic profiling, and nutritional intervention studies. Paired with a metal-free carbon-dot nanozyme assay, it helps researchers separate amino acid-driven biology from analytical interference rather than treating threonine as a direct ALP inhibitor.

• 10074-G5: Applied c-Myc Inhibitor Workflows

  2026-08-27

  Use 10074-G5 to connect c-Myc/Max disruption with apoptosis, cell-cycle, EMT, TERT, and NFκB readouts in cancer research. This practical guide translates mechanistic findings from esophageal adenocarcinoma models into dose-selection, assay, troubleshooting, and tumor regression study strategies.

• 2-NBDG Glucose Uptake Assay Kit in HCC

  2026-08-27

  Discover how the 2-NBDG Glucose Uptake Assay Kit can connect transporter-dependent glucose uptake with lipid remodeling and sorafenib resistance in hepatocellular carcinoma. This evidence-led guide explains assay design, controls, interpretation, and translational limitations.

• Brefeldin A: From Golgi Block to ER Stress

  2026-08-26

  Brefeldin A is more than a vesicle transport inhibitor: it is a mechanistic probe connecting ER-to-Golgi trafficking failure with proteostasis, ER stress, and cell fate. This guide shows how to design and interpret BFA assays without confusing transport effects with downstream apoptosis.

• I-BET-762: From BET Binding to Ferroptosis

  2026-08-26

  I-BET-762 is a selective BET inhibitor that connects chromatin-reader biology with ferroptosis, inflammation, and cancer biology research. This mechanism-first guide explains how to design and interpret assays without confusing BET-family effects with BRD4-specific mechanisms.

• Azathramycin A: Mtb Ribosome Research Guide

  2026-08-25

  Azathramycin A is a macrolide antibiotic and ribosome-binding research compound directed toward Mycobacterium tuberculosis protein synthesis. This guide distinguishes its documented biochemical rationale, product handling parameters, degradation chemistry, and research limitations from evidence generated with azithromycin itself.

• Cy3 Goat Anti-Mouse IgG (H+L) Antibody Workflow

  2026-08-25

  Use this Cy3 secondary antibody to convert mouse-primary-based HMGB1 validation into a sensitive, visually resolved assay workflow. Practical guidance covers immunofluorescence, western blotting, flow cytometry, controls, storage, and troubleshooting for biomarker research.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page